These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 23272943

  • 1. Influenza A virus nucleoprotein derived from Escherichia coli or recombinant vaccinia (Tiantan) virus elicits robust cross-protection in mice.
    Huang B, Wang W, Li R, Wang X, Jiang T, Qi X, Gao Y, Tan W, Ruan L.
    Virol J; 2012 Dec 29; 9():322. PubMed ID: 23272943
    [Abstract] [Full Text] [Related]

  • 2. Protective Efficacy of the Conserved NP, PB1, and M1 Proteins as Immunogens in DNA- and Vaccinia Virus-Based Universal Influenza A Virus Vaccines in Mice.
    Wang W, Li R, Deng Y, Lu N, Chen H, Meng X, Wang W, Wang X, Yan K, Qi X, Zhang X, Xin W, Lu Z, Li X, Bian T, Gao Y, Tan W, Ruan L.
    Clin Vaccine Immunol; 2015 Jun 29; 22(6):618-30. PubMed ID: 25834017
    [Abstract] [Full Text] [Related]

  • 3. Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats.
    Wang W, Huang B, Wang X, Tan W, Ruan L.
    Virol Sin; 2019 Oct 29; 34(5):583-591. PubMed ID: 31240620
    [Abstract] [Full Text] [Related]

  • 4. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.
    Lei H, Peng X, Jiao H, Zhao D, Ouyang J.
    Microb Cell Fact; 2015 Aug 05; 14():111. PubMed ID: 26242406
    [Abstract] [Full Text] [Related]

  • 5. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses.
    Altstein AD, Gitelman AK, Smirnov YA, Piskareva LM, Zakharova LG, Pashvykina GV, Shmarov MM, Zhirnov OP, Varich NP, Ilyinskii PO, Shneider AM.
    Arch Virol; 2006 May 05; 151(5):921-31. PubMed ID: 16292596
    [Abstract] [Full Text] [Related]

  • 6. Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses.
    Li Z, Gabbard JD, Mooney A, Gao X, Chen Z, Place RJ, Tompkins SM, He B.
    J Virol; 2013 May 05; 87(10):5985-93. PubMed ID: 23514880
    [Abstract] [Full Text] [Related]

  • 7. Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant.
    Zheng M, Liu F, Shen Y, Wang S, Xu W, Fang F, Sun B, Xie Z, Chen Z.
    Hum Vaccin Immunother; 2015 May 05; 11(2):397-406. PubMed ID: 25607884
    [Abstract] [Full Text] [Related]

  • 8. Towards a universal vaccine for avian influenza: protective efficacy of modified Vaccinia virus Ankara and Adenovirus vaccines expressing conserved influenza antigens in chickens challenged with low pathogenic avian influenza virus.
    Boyd AC, Ruiz-Hernandez R, Peroval MY, Carson C, Balkissoon D, Staines K, Turner AV, Hill AV, Gilbert SC, Butter C.
    Vaccine; 2013 Jan 11; 31(4):670-5. PubMed ID: 23200938
    [Abstract] [Full Text] [Related]

  • 9. Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice.
    Chowdhury MY, Seo SK, Moon HJ, Talactac MR, Kim JH, Park ME, Son HY, Lee JS, Kim CJ.
    Virol J; 2014 Feb 06; 11():21. PubMed ID: 24502341
    [Abstract] [Full Text] [Related]

  • 10. A single dose of DNA vaccine based on conserved H5N1 subtype proteins provides protection against lethal H5N1 challenge in mice pre-exposed to H1N1 influenza virus.
    Chang H, Huang C, Wu J, Fang F, Zhang W, Wang F, Chen Z.
    Virol J; 2010 Aug 21; 7():197. PubMed ID: 20727202
    [Abstract] [Full Text] [Related]

  • 11. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M, Tao P, Li J, Zhou S, Guo D, Pan Z.
    J Virol Methods; 2008 Dec 21; 154(1-2):121-7. PubMed ID: 18789973
    [Abstract] [Full Text] [Related]

  • 12. Expression of H3N2 nucleoprotein in maize seeds and immunogenicity in mice.
    Nahampun HN, Bosworth B, Cunnick J, Mogler M, Wang K.
    Plant Cell Rep; 2015 Jun 21; 34(6):969-80. PubMed ID: 25677970
    [Abstract] [Full Text] [Related]

  • 13. Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.
    Altenburg AF, Magnusson SE, Bosman F, Stertman L, de Vries RD, Rimmelzwaan GF.
    Clin Exp Immunol; 2017 Oct 21; 190(1):19-28. PubMed ID: 28665497
    [Abstract] [Full Text] [Related]

  • 14. Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice.
    Asthagiri Arunkumar G, McMahon M, Pavot V, Aramouni M, Ioannou A, Lambe T, Gilbert S, Krammer F.
    Vaccine; 2019 Sep 03; 37(37):5567-5577. PubMed ID: 31399277
    [Abstract] [Full Text] [Related]

  • 15. Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice.
    Brewoo JN, Powell TD, Jones JC, Gundlach NA, Young GR, Chu H, Das SC, Partidos CD, Stinchcomb DT, Osorio JE.
    Vaccine; 2013 Apr 03; 31(14):1848-55. PubMed ID: 23376279
    [Abstract] [Full Text] [Related]

  • 16. A DNA vaccine-encoded nucleoprotein of influenza virus fails to induce cellular immune responses in a diabetic mouse model.
    Jamali A, Sabahi F, Bamdad T, Hashemi H, Mahboudi F, Kheiri MT.
    Clin Vaccine Immunol; 2010 Apr 03; 17(4):683-7. PubMed ID: 20164252
    [Abstract] [Full Text] [Related]

  • 17. Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge.
    McMahon M, Asthagiri Arunkumar G, Liu WC, Stadlbauer D, Albrecht RA, Pavot V, Aramouni M, Lambe T, Gilbert SC, Krammer F.
    Front Immunol; 2019 Apr 03; 10():2005. PubMed ID: 31497029
    [Abstract] [Full Text] [Related]

  • 18. Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine.
    Ashraf S, Kong W, Wang S, Yang J, Curtiss R.
    Vaccine; 2011 May 23; 29(23):3990-4002. PubMed ID: 21466806
    [Abstract] [Full Text] [Related]

  • 19. Incorporation of conserved nucleoprotein into influenza virus-like particles could provoke a broad protective immune response in BALB/c mice and chickens.
    Xue C, Tian G, Chen X, Liu Q, Ma J, Xu S, Li X, Chen H, Cao Y.
    Virus Res; 2015 Jan 02; 195():35-42. PubMed ID: 25312452
    [Abstract] [Full Text] [Related]

  • 20. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC, Lin CY, Tsou YT, Jan JT, Wu SC.
    J Virol; 2015 Jul 02; 89(14):7224-34. PubMed ID: 25948745
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.